相关实验视频
Updated: Jun 21, 2025
07:45
Retroductal Nanoparticle Injection to the Murine Submandibular Gland
Published on: May 3, 2018
10.0K
"像阿布拉克桑"的放射性敏感剂用于实地口腔癌治疗
Zijian Gong1, Yixuan Fu1, Yuan Gao1
1Central Laboratory, Department of Geriatric Dentistry, Beijing Laboratory of Biomedical Materials, NMPA Key Laboratory for Dental Materials, National Engineering Laboratory for Digital and Material, Technology of Stomatology, Peking University School and Hospital of Stomatology, Beijing, 100081, P. R. China.
概括
这项研究引入了一种新的纳米粒子,它释放氧气来对抗瘤缺氧,增强放射治疗的有效性. 这种方法有望改善口腔癌治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 瘤缺氧显著降低了放射治疗的疗效.
- 开发有效的放射敏感剂对于癌症治疗至关重要.
- 现有的放射敏感剂在临床应用方面存在局限性.
研究的目的:
- 开发一种新,安全,高效的放射敏感剂,以克服瘤缺氧.
- 为了创建一个人血清白蛋白修饰的过氧化纳米粒子系统 (CaO2-HSA).
- 评估CaO2-HSA在增强口腔癌放射治疗中的疗效.
主要方法:
- 使用生物矿物化诱导的自我组装合成了CaO2-HSA纳米粒子.
- 研究了瘤组织中的纳米粒子积累和氧气释放.
- 对CaO2-HSA对瘤细胞死亡和生长抑制的影响在体外和体内进行了评估.
- 敏感增强比 (SER) 与临床标准进行了比较.
主要成果:
- CaO2-HSA纳米粒子有效地传递给瘤,并分解释放氧气,缓解缺氧.
- 该系统诱导了过载和免疫细胞死亡.
- 获得了高敏感增强比率 (SER=3.47),超过了临床的糖.
- 在动物模型中观察到明显的口腔癌生长抑制.
结论:
- CaO2-HSA纳米颗粒代表了克服瘤缺氧的有希望的放射敏感剂.
- 没有重金属的CaO2-HSA生物相容性增强了其治疗潜力.
- 这种新的系统为口腔癌治疗提供了一个易于准备和高度有效的策略.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
158
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
158